Siemens Fonds Invest GmbH Acquires 1,448 Shares of Humana Inc. (NYSE:HUM)

Siemens Fonds Invest GmbH lifted its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 23.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,567 shares of the insurance provider's stock after purchasing an additional 1,448 shares during the period. Siemens Fonds Invest GmbH's holdings in Humana were worth $1,920,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Transcend Capital Advisors LLC lifted its position in shares of Humana by 399.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock worth $924,000 after purchasing an additional 2,914 shares during the last quarter. Retirement Systems of Alabama raised its stake in Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock worth $55,563,000 after acquiring an additional 192,801 shares during the period. Charles Schwab Investment Management Inc. raised its stake in Humana by 7.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock worth $244,811,000 after acquiring an additional 65,735 shares during the period. Secure Asset Management LLC acquired a new stake in Humana during the fourth quarter worth about $244,000. Finally, denkapparat Operations GmbH acquired a new stake in Humana during the fourth quarter worth about $323,000. Institutional investors own 92.38% of the company's stock.

Humana Trading Up 3.2%

Humana stock traded up $7.89 during midday trading on Tuesday, reaching $255.23. The stock had a trading volume of 1,878,205 shares, compared to its average volume of 1,770,415. The firm's fifty day simple moving average is $262.90 and its two-hundred day simple moving average is $269.48. Humana Inc. has a twelve month low of $212.45 and a twelve month high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market cap of $30.80 billion, a price-to-earnings ratio of 25.65, a PEG ratio of 2.05 and a beta of 0.49.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. Humana had a net margin of 1.02% and a return on equity of 11.70%. The firm had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. During the same quarter last year, the business posted $7.23 EPS. The company's revenue was up 8.4% on a year-over-year basis. Equities analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.39%. Humana's payout ratio is 25.04%.

Analyst Ratings Changes

Several brokerages have commented on HUM. Guggenheim began coverage on shares of Humana in a research note on Wednesday, April 9th. They issued a "buy" rating and a $326.00 price target on the stock. Truist Financial dropped their price target on shares of Humana from $325.00 to $305.00 and set a "hold" rating on the stock in a research note on Monday, May 12th. Barclays raised their price target on shares of Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a research note on Friday, April 11th. JPMorgan Chase & Co. dropped their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. Finally, Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 price target on shares of Humana in a research note on Thursday, May 1st. Seventeen investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $286.81.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.